Showing results (41-50 of 172) with videos related to

Sort By:
Pageof 18
Biological Chemistry|April 4, 2002
Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activatorsAdriano Angelucci, Claudio Festuccia, Gabriele D'Andrea, et al.
Molecular Therapy. Nucleic Acids|September 2, 2015
Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2Mattia Capulli, Antonio Maurizi, Luca Ventura, et al.
Journal of Cellular Biochemistry|March 14, 2002
Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV)Nadia Rucci, Silvia Migliaccio, Bianca Maria Zani, et al.
International Journal of Molecular Sciences|January 20, 2018
"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal CancerAdriano Angelucci, Simona Delle Monache, Alessio Cortellini, et al.
Cancers|June 6, 2020
Src Family Kinases as Therapeutic Targets in Advanced Solid Tumors: What We Have Learned so FarStefano Martellucci, Letizia Clementi, Samantha Sabetta, et al.
Experimental Cell Research|October 10, 2002
Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagementClaudio Festuccia, Adriano Angelucci, Giovanni Gravina, et al.
Bone|March 5, 2018
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical developmentAntonio Maurizi, Mattia Capulli, Rajvi Patel, et al.
Life Sciences|July 9, 2026
Generation of a P4hb<sup>Y393C</sup> mouse model of cole-carpenter syndrome and therapeutic proof-of-conceptAntonio Maurizi, Elisa Pucci, Piergiorgio Patrizii, et al.
International Journal of Molecular Sciences|January 21, 2022
Lipocalin 2 Influences Bone and Muscle Phenotype in the <i>MDX</i> Mouse Model of Duchenne Muscular DystrophyMarco Ponzetti, Argia Ucci, Antonio Maurizi, et al.
Pageof 18